Eli Lilly Canada Inc. v. Mylan Pharmaceuticals ULC, 2020 FC 816
| Jurisdiction | Federal Jurisdiction (Canada) |
| Court | Federal Court (Canada) |
| Citation | 2020 FC 816 |
| Date | 10 September 2020 |
-
- This document is available in original version only for vLex customers
View this document and try vLex for 7 days - TRY VLEX
- This document is available in original version only for vLex customers
11 practice notes
-
Eli Lilly Canada Inc. v. Apotex Inc., 2020 FC 814
...Patent] are exposed in case docket T-1627-16 and will be placed on this file (Eli Lilly Canada Inc. and als. v Mylan Pharmaceuticals ULC, 2020 FC 816). [3] Hence, these additional reasons are concerned with the validity and infringement, at the liability phase, of the 540 Patent, entitled “......
-
AbbVie Corporation v. Jamp Pharma Corporation, 2023 FC 1520
...FC 718 [Hoffman-La Roche]; Alcon Canada Inc v Apotex Inc, 2014 FC 699 [Alcon Canada]; Eli Lilly Canada Inc v Mylan Pharmaceuticals ULC, 2020 FC 816 [Eli Lilly 2020]; Swist v MEG Energy Corp, 2021 FC 10. [159] In contrast, AbbVie argues that, where the disclosure broadly includes or encompas......
-
Allergan Inc. v. Juno Pharmaceuticals Corp., 2023 FC 1686
...begins with the claims of the patent and only looks to the disclosure when necessary: Eli Lilly Canada Inc v Mylan Pharmaceuticals ULC, 2020 FC 816 at paras 291, 293, 297-298 and 301; AstraZeneca Canada Inc v Apotex Inc, 2014 FC 638 at paras 267-269. Any particular result from the alleged i......
-
Teva Canada Innovation v. Pharmascience Inc., 2020 FC 1158
...that the prior art at issue in those cases met the disclosure requirement (e.g., Eli Lilly Canada Inc v Mylan Pharmaceuticals ULC, 2020 FC 816; Hoffman-La Roche Limited v Apotex Inc, 2013 FC 718; and Shire Biochem Inc v Canada (Health), 2008 FC 538). The jurisprudence relied on does not set......
Request a trial to view additional results
8 cases
-
Eli Lilly Canada Inc. v. Apotex Inc., 2020 FC 814
...Patent] are exposed in case docket T-1627-16 and will be placed on this file (Eli Lilly Canada Inc. and als. v Mylan Pharmaceuticals ULC, 2020 FC 816). [3] Hence, these additional reasons are concerned with the validity and infringement, at the liability phase, of the 540 Patent, entitled “......
-
AbbVie Corporation v. Jamp Pharma Corporation, 2023 FC 1520
...FC 718 [Hoffman-La Roche]; Alcon Canada Inc v Apotex Inc, 2014 FC 699 [Alcon Canada]; Eli Lilly Canada Inc v Mylan Pharmaceuticals ULC, 2020 FC 816 [Eli Lilly 2020]; Swist v MEG Energy Corp, 2021 FC 10. [159] In contrast, AbbVie argues that, where the disclosure broadly includes or encompas......
-
Allergan Inc. v. Juno Pharmaceuticals Corp., 2023 FC 1686
...begins with the claims of the patent and only looks to the disclosure when necessary: Eli Lilly Canada Inc v Mylan Pharmaceuticals ULC, 2020 FC 816 at paras 291, 293, 297-298 and 301; AstraZeneca Canada Inc v Apotex Inc, 2014 FC 638 at paras 267-269. Any particular result from the alleged i......
-
Teva Canada Innovation v. Pharmascience Inc., 2020 FC 1158
...that the prior art at issue in those cases met the disclosure requirement (e.g., Eli Lilly Canada Inc v Mylan Pharmaceuticals ULC, 2020 FC 816; Hoffman-La Roche Limited v Apotex Inc, 2013 FC 718; and Shire Biochem Inc v Canada (Health), 2008 FC 538). The jurisprudence relied on does not set......
Request a trial to view additional results
3 firm's commentaries
-
IP Litigation 2020 Year In Review
...73, 74, 77. 26. Canmar Foods Ltd. v. TA Foods Ltd., 2021 FCA 7 at para. 77. 27. Eli Lilly Canada Inc. v. Mylan Pharmaceuticals ULC, 2020 FC 816 at para. 126 (Justice 28. Eli Lilly Canada Inc. v. Mylan Pharmaceuticals ULC, 2020 FC 816 at para. 128. 29. Biogen Canada Inc et al v. Taro Pha......
-
Federal Court finds Eli Lilly’s tadalafil dosage form and process patents invalid
...on the bases of anticipation and obviousness: Eli Lilly v Mylan; Eli Lilly v Teva; Eli Lilly v Pharmascience and Riva; Eli Lilly v Apotex, 2020 FC 816 and Eli Lilly v Apotex, 2020 FC The 684 Patent The 684 patent relates to a unit dosage form of tadalafil and its use for the treatment of se......
-
Life Sciences 2020 Year In Review
...to get the invention to work. The decision is under appeal. Selection patent In Eli Lilly Canada Inc. v. Mylan Pharmaceuticals ULC, 2020 FC 816, Justice St-Louis of the Federal Court did not consider Lilly's patent to low dose (between 1 and 20 mg) tadalafil to be a patentable selection of ......